Novel pathway has potential to slow progression of pulmonary fibrosis Date: March 25, 2025 Source: Elsevier Summary: Researchers have found a potential new way to slow the progression of lung ...

Mar. 25, 2025 — Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting the expression or function of Piezo2, a receptor ...

When breathing becomes increasingly difficult with no clear explanation, idiopathic pulmonary fibrosis (IPF) might be the culprit behind the concerning symptoms. This rare yet devastating lung ...

Basal stem cells taken from the upper part of a patient’s respiratory tract can be expanded in the lab and then transplanted back into their lungs to treat idiopathic pulmonary fibrosis (IPF), ...

More information: Zhi Yang et al, Distinct mural cells and fibroblasts promote pathogenic plasma cell accumulation in idiopathic pulmonary fibrosis, European Respiratory Journal (2025). DOI: 10. ...

A new discovery from Rutgers Health scientists could lead to better treatments for a deadly lung disease called Idiopathic Pulmonary Fibrosis (IPF). This condition causes the lungs to become ...

In addition to detecting new infections, the test is intended to enable care teams to monitor chronic infections in people with cystic fibrosis. A Pseudomonas infection is usually diagnosed by ...

Teamwork: A Multidisciplinary Approach to Early Lung Cancer: Beyond Standard of Care NYU lung cancer specialists discuss advances in adjuvant therapy for non–small cell lung cancer, including ...

It can harm nearly every organ in your body and increase your risk of certain health conditions like glaucoma, cancer, and lung disease. It can also increase inflammation throughout your body and ...

Vertex Pharma has chosen the three-drug combination it intends to submit for approval later this year for cystic fibrosis, in a bid to add another product to its stable. The US company has plumped ...